| Code | 04625 | ||||||||||
| MA number | 31/0059/11-S | ||||||||||
| Product Form: | tbl flm 30x80 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | TAD Pharma GmbH, Germany | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 03.02.2011 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Atoridor 80 mg_02.2025.pdf
|
| SPC: |
SPC_Atoridor 80 mg_02.2025.pdf
|
| Safety feature | Yes |
| Data update: | 27.10.2021 |
